Skip to content

Clinical Evaluation of Proclear Toric and Biofinity Toric

Clinical Evaluation of Proclear Toric and Biofinity Toric

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06431061
Enrollment
37
Registered
2024-05-28
Start date
2024-06-04
Completion date
2024-11-13
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The aim of this study is to compare the short-term clinical performance of two Toric contact lenses.

Detailed description

The aim of the study is to evaluate and compare the performance of two soft toric contact lenses in existing soft toric lens wearers in a short term (15 minutes wear) study.

Interventions

DEVICELens A (omafilcon B)

15 minutes of daily wear.

15 minutes of daily wear.

Sponsors

Centre for Ocular Research & Education, Canada
CollaboratorOTHER
CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Are at least 17 years of age and has full legal capacity to volunteer. 2. Have understood and signed an information consent letter. 3. Are willing and able to follow instructions and maintain the appointment schedule. 4. Are an adapted soft toric contact lens wearer. 5. Do not habitually wear either of the two study lens types. 6. Have a vertex-corrected contact lens prescription with a spherical component of +4.00D to -9.00D in combination with astigmatism of no less than -0.75D and no more than -2.25D in each eye. 7. Can achieve best corrected distance visual acuity of +0.10 logMAR (subjective refraction) or better in each eye. 8. Can be fitted with and achieve a distance visual acuity of +0.18 logMAR or better in each eye with the study contact lenses.

Exclusion criteria

1. Are participating in any concurrent clinical or research study. 2. Have any known active ocular disease and/or infection or slit lamp findings that would contraindicate contact lens use. 3. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable. 4. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. 5. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study. 6. Have a history of not achieving comfortable CL use (5 days per week; \> 8 hours/day) 7. Are an employee of the Centre for Ocular Research & Education directly involved in the study (i.e. on the delegation log).

Design outcomes

Primary

MeasureTime frameDescription
Overall Fit AcceptanceAfter 15 minutes of continuous wearOverall fit acceptance will be measured on scale of (0-4) where (0=Should not be worn and 4=Perfect)

Countries

Canada

Participant flow

Pre-assignment details

Thirty-eight Participants were screened. One Participant was not eligible due to screening failure. All the participants who were eligible in the study were included in the analysis. (n=37)

Participants by arm

ArmCount
All Study Participants
Includes all Study Participants
37
Total37

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous29.6 years
STANDARD_DEVIATION 13
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 37
other
Total, other adverse events
0 / 370 / 37
serious
Total, serious adverse events
0 / 370 / 37

Outcome results

Primary

Overall Fit Acceptance

Overall fit acceptance will be measured on scale of (0-4) where (0=Should not be worn and 4=Perfect)

Time frame: After 15 minutes of continuous wear

Population: All the participants who were eligible in the study were included in the analysis. (n=37)

ArmMeasureValue (MEAN)Dispersion
Lens A (Omafilcon B)Overall Fit Acceptance3.5 Units on ScaleStandard Deviation 0.7
Lens B (Comfilcon A)Overall Fit Acceptance3.8 Units on ScaleStandard Deviation 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026